| Author | : Food and Drug Administration |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 1039 |
| Release | : 2005 |
| Genre | : Medical |
| ISBN | : 1934899755 |
FDA Orange Book 25th Edition - 2005 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 28th Edition (2008)
| Author | : Food and Drug Administration |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 1103 |
| Release | : 2008 |
| Genre | : Medical |
| ISBN | : 193489978X |
FDA Orange Book 28th Edition - 2008 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009)
| Author | : Food and Drug Administration |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 1161 |
| Release | : 2009 |
| Genre | : Medical |
| ISBN | : 1934899798 |
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 32nd Edition (2012)
| Author | : Food and Drug Administration |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 1299 |
| Release | : 2012 |
| Genre | : Medical |
| ISBN | : 1934899828 |
FDA Orange Book 32nd Edition - 2012 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 31st Edition (2011)
| Author | : Food and Drug Administration |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 1253 |
| Release | : 2011 |
| Genre | : Medical |
| ISBN | : 193489981X |
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)
MOVIPREP Drug Profile, 2023
| Author | : DrugPatentWatch |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 101 |
| Release | : 2023-08-15 |
| Genre | : Medical |
| ISBN | : 1934899836 |
MOVIPREP Drug Profile, 2023
This report focuses on MOVIPREP and covers the following critical aspects of this drug:
- United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 30th Edition (2010)
| Author | : Food and Drug Administration |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 1115 |
| Release | : 2010 |
| Genre | : Medical |
| ISBN | : 1934899801 |
FDA Orange Book 30th Edition - 2010 (Approved Drug Products With Therapeutic Equivalence Evaluations)
NESINA Drug Profile, 2023
| Author | : DrugPatentWatch |
| Publisher | : DrugPatentWatch.com |
| Total Pages | : 100 |
| Release | : 2023-08-15 |
| Genre | : Medical |
| ISBN | : 1934899852 |
NESINA Drug Profile, 2023
This report focuses on NESINA and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
